Harahap, R.H. et al. 2020. Fibroblast Growth Factor-23 (FGF-23) in Patients with Regular Hemodialysis: A Risk Factor for Restless Legs Syndrome. Journal of Endocrinology, Tropical Medicine, and Infectious Disease (JETROMI). 2, 3 (Aug. 2020), 133–143. DOI:https://doi.org/10.32734/jetromi.v2i3.4293.